List of Tables
Table 1. Global Neurological Disease Model Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Neurological Disease Model Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Neurological Disease Model Chip Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Neurological Disease Model Chip Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Neurological Disease Model Chip Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Neurological Disease Model Chip Sales by Region (2020-2025) & (K Units)
Table 8. Global Neurological Disease Model Chip Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Neurological Disease Model Chip Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Neurological Disease Model Chip Sales Share by Manufacturers (2020-2025)
Table 12. Global Neurological Disease Model Chip Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Neurological Disease Model Chip Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Neurological Disease Model Chip by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Disease Model Chip as of 2024)
Table 16. Global Neurological Disease Model Chip Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Neurological Disease Model Chip Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Neurological Disease Model Chip Manufacturing Base and Headquarters
Table 19. Global Neurological Disease Model Chip Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Neurological Disease Model Chip Sales by Type (2020-2025) & (K Units)
Table 23. Global Neurological Disease Model Chip Sales by Type (2026-2031) & (K Units)
Table 24. Global Neurological Disease Model Chip Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Neurological Disease Model Chip Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Neurological Disease Model Chip ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Neurological Disease Model Chip Sales by Application (2020-2025) & (K Units)
Table 29. Global Neurological Disease Model Chip Sales by Application (2026-2031) & (K Units)
Table 30. Neurological Disease Model Chip High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Neurological Disease Model Chip Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Neurological Disease Model Chip Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Neurological Disease Model Chip ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Neurological Disease Model Chip Growth Accelerators and Market Barriers
Table 37. North America Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Neurological Disease Model Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Neurological Disease Model Chip Growth Accelerators and Market Barriers
Table 40. Europe Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Neurological Disease Model Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Neurological Disease Model Chip Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Neurological Disease Model Chip Growth Accelerators and Market Barriers
Table 45. Southeast Asia Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Neurological Disease Model Chip Investment Opportunities and Key Challenges
Table 47. Central and South America Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Neurological Disease Model Chip Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Neurological Disease Model Chip Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Emulate Corporation Information
Table 51. Emulate Description and Major Businesses
Table 52. Emulate Product Models, Descriptions and Specifications
Table 53. Emulate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Emulate Sales Value Proportion by Product in 2024
Table 55. Emulate Sales Value Proportion by Application in 2024
Table 56. Emulate Sales Value Proportion by Geographic Area in 2024
Table 57. Emulate Neurological Disease Model Chip SWOT Analysis
Table 58. Emulate Recent Developments
Table 59. CN Bio Corporation Information
Table 60. CN Bio Description and Major Businesses
Table 61. CN Bio Product Models, Descriptions and Specifications
Table 62. CN Bio Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. CN Bio Sales Value Proportion by Product in 2024
Table 64. CN Bio Sales Value Proportion by Application in 2024
Table 65. CN Bio Sales Value Proportion by Geographic Area in 2024
Table 66. CN Bio Neurological Disease Model Chip SWOT Analysis
Table 67. CN Bio Recent Developments
Table 68. TissUse Corporation Information
Table 69. TissUse Description and Major Businesses
Table 70. TissUse Product Models, Descriptions and Specifications
Table 71. TissUse Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. TissUse Sales Value Proportion by Product in 2024
Table 73. TissUse Sales Value Proportion by Application in 2024
Table 74. TissUse Sales Value Proportion by Geographic Area in 2024
Table 75. TissUse Neurological Disease Model Chip SWOT Analysis
Table 76. TissUse Recent Developments
Table 77. AxoSim Technologies Corporation Information
Table 78. AxoSim Technologies Description and Major Businesses
Table 79. AxoSim Technologies Product Models, Descriptions and Specifications
Table 80. AxoSim Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. AxoSim Technologies Sales Value Proportion by Product in 2024
Table 82. AxoSim Technologies Sales Value Proportion by Application in 2024
Table 83. AxoSim Technologies Sales Value Proportion by Geographic Area in 2024
Table 84. AxoSim Technologies Neurological Disease Model Chip SWOT Analysis
Table 85. AxoSim Technologies Recent Developments
Table 86. Nortis Corporation Information
Table 87. Nortis Description and Major Businesses
Table 88. Nortis Product Models, Descriptions and Specifications
Table 89. Nortis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Nortis Sales Value Proportion by Product in 2024
Table 91. Nortis Sales Value Proportion by Application in 2024
Table 92. Nortis Sales Value Proportion by Geographic Area in 2024
Table 93. Nortis Neurological Disease Model Chip SWOT Analysis
Table 94. Nortis Recent Developments
Table 95. Mimetas Corporation Information
Table 96. Mimetas Description and Major Businesses
Table 97. Mimetas Product Models, Descriptions and Specifications
Table 98. Mimetas Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Mimetas Recent Developments
Table 100. SynVivo Corporation Information
Table 101. SynVivo Description and Major Businesses
Table 102. SynVivo Product Models, Descriptions and Specifications
Table 103. SynVivo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. SynVivo Recent Developments
Table 105. Axion Biosystems Corporation Information
Table 106. Axion Biosystems Description and Major Businesses
Table 107. Axion Biosystems Product Models, Descriptions and Specifications
Table 108. Axion Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Axion Biosystems Recent Developments
Table 110. Tara Biosystems Corporation Information
Table 111. Tara Biosystems Description and Major Businesses
Table 112. Tara Biosystems Product Models, Descriptions and Specifications
Table 113. Tara Biosystems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Tara Biosystems Recent Developments
Table 115. InSphero Corporation Information
Table 116. InSphero Description and Major Businesses
Table 117. InSphero Product Models, Descriptions and Specifications
Table 118. InSphero Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. InSphero Recent Developments
Table 120. Hesperos Corporation Information
Table 121. Hesperos Description and Major Businesses
Table 122. Hesperos Product Models, Descriptions and Specifications
Table 123. Hesperos Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Hesperos Recent Developments
Table 125. Kugelmeiers Corporation Information
Table 126. Kugelmeiers Description and Major Businesses
Table 127. Kugelmeiers Product Models, Descriptions and Specifications
Table 128. Kugelmeiers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Kugelmeiers Recent Developments
Table 130. Ascendance Biotechnology Corporation Information
Table 131. Ascendance Biotechnology Description and Major Businesses
Table 132. Ascendance Biotechnology Product Models, Descriptions and Specifications
Table 133. Ascendance Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Ascendance Biotechnology Recent Developments
Table 135. BioIVT Corporation Information
Table 136. BioIVT Description and Major Businesses
Table 137. BioIVT Product Models, Descriptions and Specifications
Table 138. BioIVT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. BioIVT Recent Developments
Table 140. BGI Genomics Corporation Information
Table 141. BGI Genomics Description and Major Businesses
Table 142. BGI Genomics Product Models, Descriptions and Specifications
Table 143. BGI Genomics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. BGI Genomics Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Disease Model Chip Product Picture
Figure 2. Global Neurological Disease Model Chip Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Neuron Chip Product Picture
Figure 4. Brain Chip Product Picture
Figure 5. Brain Organ Chip Product Picture
Figure 6. Global Neurological Disease Model Chip Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceutical R&D
Figure 8. Neuroscience Research
Figure 9. Clinical Diagnosis
Figure 10. Neurological Disease Model Chip Report Years Considered
Figure 11. Global Neurological Disease Model Chip Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 13. Global Neurological Disease Model Chip Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Neurological Disease Model Chip Revenue Market Share by Region (2020-2031)
Figure 15. Global Neurological Disease Model Chip Sales (2020-2031) & (K Units)
Figure 16. Global Neurological Disease Model Chip Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Neurological Disease Model Chip Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Neurological Disease Model Chip Sales Volume Market Share in 2024
Figure 19. Global Neurological Disease Model Chip Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Neuron Chip Revenue Market Share by Manufacturer in 2024
Figure 22. Brain Chip Revenue Market Share by Manufacturer in 2024
Figure 23. Brain Organ Chip Revenue Market Share by Manufacturer in 2024
Figure 24. Global Neurological Disease Model Chip Sales Market Share by Type (2020-2031)
Figure 25. Global Neurological Disease Model Chip Revenue Market Share by Type (2020-2031)
Figure 26. Global Neurological Disease Model Chip Sales Market Share by Application (2020-2031)
Figure 27. Global Neurological Disease Model Chip Revenue Market Share by Application (2020-2031)
Figure 28. North America Neurological Disease Model Chip Sales YoY (2020-2031) & (K Units)
Figure 29. North America Neurological Disease Model Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Neurological Disease Model Chip Sales Revenue (US$ Million) in 2024
Figure 31. North America Neurological Disease Model Chip Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Neurological Disease Model Chip Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Neurological Disease Model Chip Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Neurological Disease Model Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Neurological Disease Model Chip Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Neurological Disease Model Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Neurological Disease Model Chip Sales Revenue (US$ Million) in 2024
Figure 41. Europe Neurological Disease Model Chip Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Neurological Disease Model Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Neurological Disease Model Chip Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Neurological Disease Model Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 46. France Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Neurological Disease Model Chip Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Neurological Disease Model Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Neurological Disease Model Chip Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Neurological Disease Model Chip Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Neurological Disease Model Chip Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Neurological Disease Model Chip Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Neurological Disease Model Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 61. India Neurological Disease Model Chip Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Neurological Disease Model Chip Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Neurological Disease Model Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Neurological Disease Model Chip Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Neurological Disease Model Chip Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Neurological Disease Model Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Neurological Disease Model Chip Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Neurological Disease Model Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Neurological Disease Model Chip Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Neurological Disease Model Chip Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Neurological Disease Model Chip Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Neurological Disease Model Chip Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Neurological Disease Model Chip Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Neurological Disease Model Chip Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Neurological Disease Model Chip Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Neurological Disease Model Chip Revenue (2020-2025) & (US$ Million)
Figure 82. Neurological Disease Model Chip Industry Chain Mapping
Figure 83. Regional Neurological Disease Model Chip Manufacturing Base Distribution (%)
Figure 84. Global Neurological Disease Model Chip Production Market Share by Region (2020-2031)
Figure 85. Neurological Disease Model Chip Production Process
Figure 86. Regional Neurological Disease Model Chip Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
